ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

REGN Regeneron Pharmaceuticals Inc

955.76
-14.21 (-1.46%)
May 08 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Regeneron Pharmaceuticals Inc REGN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-14.21 -1.46% 955.76 20:00:00
Open Price Low Price High Price Close Price Prev Close
969.90 952.14 971.86 955.76 969.97
more quote information »

Recent News

Date Time Source Heading
5/08/20249:05IHNWFeaturedElement79 Gold Corp Successfully Closes Maverick Springs Option Agreement
5/08/202406:00GLOBELatest DB-OTO Results Show Dramatically Improved Hearing to..
5/06/202416:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/06/202416:05GLOBERegeneron Announces Investor Conference Presentations
5/02/202406:30GLOBERegeneron Reports First Quarter 2024 Financial and Operating..
4/29/202407:00GLOBEEYLEA® HD (aflibercept) Injection 8 mg Presentations at ARVO..
4/25/202407:00GLOBERegeneron and Mammoth Biosciences Collaborate to Pursue..
4/24/202410:05GLOBERegeneron to Showcase Progress in Advancing Novel..
4/22/202417:54GLOBERegeneron to Highlight Advances in Genetic Medicine Research..
4/16/202407:18IHMARKETNEWSEricsson Soars with 66% Net Profit Growth; Live Nation Under..
4/11/202407:24IHMARKETNEWSCostco Increases Dividend by 14%, Meta Introduces ‘Artemis’..
4/07/202416:00GLOBELinvoseltamab Pivotal Data Presented at AACR Reinforce High..
4/01/202416:05GLOBERegeneron to Report First Quarter 2024 Financial and..
3/25/202407:00GLOBERegeneron Provides Update on Biologics License Application..
3/12/202423:55PRNUSHigh School Seniors Win $1.8 Million at Regeneron Science..
3/12/202421:30GLOBEHigh School Seniors Win $1.8 Million at Regeneron Science..
3/11/202407:00GLOBEPraluent® (alirocumab) Injection Receives FDA Approval to..
3/08/202407:00GLOBEEYLEA® HD (aflibercept) Injection 8 mg Pivotal Data in Wet..
3/05/202416:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202416:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/01/202416:14EDGAR2Form 144 - Report of proposed sale of securities
2/28/202416:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/28/202416:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/28/202416:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/26/202416:34EDGAR2Form 144 - Report of proposed sale of securities
2/26/202416:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/26/202416:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/26/202416:07EDGAR2Form 144 - Report of proposed sale of securities
2/26/202416:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/26/202415:25EDGAR2Form 144 - Report of proposed sale of securities
2/23/202416:04EDGAR2Form 144 - Report of proposed sale of securities
2/23/202401:00GLOBEDupixent® (dupilumab) sBLA Accepted for FDA Priority Review..
2/22/202417:10EDGAR2Form 144 - Report of proposed sale of securities
2/22/202416:06EDGAR2Form 144 - Report of proposed sale of securities
2/21/202407:00GLOBELinvoseltamab BLA for Treatment of Relapsed/Refractory..
2/20/202416:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/16/202416:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/16/202400:59GLOBEJapan First in the World to Approve Dupixent® (dupilumab)..
2/14/202417:08EDGAR2Form 144 - Report of proposed sale of securities
2/12/202416:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/12/202416:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/09/202418:19EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/09/202416:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/09/202416:04EDGAR2Form 144 - Report of proposed sale of securities
2/09/202412:22EDGAR2Form 144 - Report of proposed sale of securities
2/08/202416:56EDGAR2Form 144 - Report of proposed sale of securities
2/08/202416:26EDGAR2Form 144 - Report of proposed sale of securities
2/08/202416:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/08/202416:01EDGAR2Form 3 - Initial statement of beneficial ownership of..
2/07/202417:59EDGAR2Form 144 - Report of proposed sale of securities
2/07/202417:07EDGAR2Form 144 - Report of proposed sale of securities

Your Recent History

Delayed Upgrade Clock